Table 1.
EBV cancers and their respective latent states and gene products.
| Healthy individuals | GC or EN NK/T-cell lymphoma | BL | CHL | NPC | EBV+ LBCL or PTLD | |
|---|---|---|---|---|---|---|
| EBNA1 | + | + | + | + | + | |
| LMP1 | + | + | + | |||
| LMP2 | + | + | + | + | ||
| EBER | + | + | + | + | + | + |
| BART miRNA | + | + | + | + | ||
| EBNA2 | + | |||||
| EBNA3A/3B/3C | + | |||||
| Latency state | 0 | I | I | II | I/II | III |
Abbreviations: NPC: nasopharyngeal carcinoma; BL: Burkitt lymphoma; CHL: classic Hodgkin lymphoma; EBV: Epstein Barr virus; EN: extranodal; GC: gastric carcinoma; LBCL: Large B-cell lymphoma; NK: natural killer; NPC: nasopharyngeal carcinoma; PTLD: posttransplant lymphoproliferative disorder